We have another study for seniors with Type 1 diabetes (T1D) and one for people starting on the MiniMed 670G system.
We initiated a pilot study for Dexcom users with T1D who are 65 and older and have an iPhone. We are testing if we can create an automated daily remote monitoring system of patient's Dexcom data to see if we can identify people who might be having hypoglycemia episodes to reduce the low glucose events. Currently seniors have higher rates of hypoglycemia and low use of continuous glucose monitoring technology and the study will assess the time using the technology, measure the impact on quality of life and evaluate costs for care.
The study is called: Telemedicine Monitoring of Nocturnal Incidents of Treatment-Requiring Hypoglycemia in Older Adults with T1DM - A Feasibility Study, or "Tele-Monitor T1DM" and we are enrolling up to 10 participants now.
We also want to enroll patients who are starting on the Mini-Med 670G system to have an independent evaluation of the system and to gather insights on starting closed loop systems.
This is known as Hybrid Closed Loop Insulin Delivery System Data Collection or HYCLO and we are in active enrollment. Please contact us if you are getting ready to start on the system; we need to collect data before you start on any training on the 670G system.
Our patient's participation in studies has contributed to diabetes treatment and created major policy changes. The participants in the ReplaceBG Study help to lead the way to making insulin dosing decisions off the Dexcom, which led to Medicare approval and the new no-calibration Dexcom G6 and Freestyle Libre systems.
Your contributions are vital in giving us the support we need to conduct studies like Tele-Monitor T1dm, the community Kids-N-Fitness or low literacy teaching guides for insulin pens, pumps and CGM devices. Please consider contributing what you can.
If you are interested in either of the trials, please contact Mark Harmel at email@example.com or 310-646-6509.